YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (1558.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap7.92B
Enterprise Value8.75B
P/E Ratio24.95
PEG Ratio0.25
Price/Sales Ratio3.24
Price/Book Ratio1.42
Enterprise/Revenue3.47
Enterprise/EBITDA12.28

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.13
Operating Margin0.18
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.06

Income Statement

Revenue3.72B
Revenue/Share4.23
Gross Profit2.79B
EBITDA1.05B
Net Income482.71M
Diluted EPS0.55

Balance Sheet

Total Cash1.41B
Total Cash/Share1.6
Total Debt2.23B
Total Debt/Equity0.26
Current Ratio1.77
Book Value Per Share9.67

Price History

52-Week Change55.69
52-Week High17.74
52-Week Low7.92
Moving Average 50 Days15.09
Moving Average 200 Days11.38

Statistics

Average Volume9.3M
Shares Outstanding879.97M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.42
Trailing Annual Dividend Yield10.32
Payout Ratio0
Last Split Factor2:1
Last Split DateJune 09, 2020
AD